Britain approves AstraZeneca's preventative COVID therapy - Reuters.com
3/17/2022 12:00:00 AM3 years 11 months ago
Britain's medicines regulator has approved AstraZeneca's <a href="https://www.reuters.com/companies/AZN.L" target="_blank">(AZN.L)</a> antibody-based COVID-19 treatment for preventing infections in adults with poor immune response, marking a major step in the…
March 17 (Reuters) - Britain's medicines regulator has approved AstraZeneca's (AZN.L) antibody-based COVID-19 treatment for preventing infections in adults with poor immune response, marking a major … [+2752 chars]
full article...